🇺🇸 FDA
Patent

US 6180110

Attenuated hepatitis a virus vaccine which grows in MRC-5 cells

expired A61KA61K2039/5254A61K2039/542

Quick answer

US patent 6180110 (Attenuated hepatitis a virus vaccine which grows in MRC-5 cells) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5254, A61K2039/542, A61K2039/545, A61K39/12